Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Pediatric Research|March 10, 2000
A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airwaysG Piedimonte, K A King, N L Holmgren, et al.Journal of Virology|February 1, 1984
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infectionsM Graves, D E Griffin, R T Johnson, et al.The New England Journal of Medicine|January 19, 1984
Measles encephalomyelitis--clinical and immunologic studiesR T Johnson, D E Griffin, R L Hirsch, et al.Lancet (London, England)|August 2, 1980
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosisP K Coyle, B R Brooks, R L Hirsch, et al.The Journal of Allergy and Clinical Immunology|August 1, 1985
Changes in plasma IgE levels during complicated and uncomplicated measles virus infectionsD E Griffin, S J Cooper, R L Hirsch, et al.Clinical Immunology and Immunopathology|April 1, 1984
Cellular immune responses during complicated and uncomplicated measles virus infections of manR L Hirsch, D E Griffin, R T Johnson, et al.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trialG Goldstein, M A Conant, G Beall, et al.The Journal of Allergy and Clinical Immunology|May 1, 1990
Thymopentin therapy reduces the clinical severity of atopic dermatitisD Y Leung, R L Hirsch, L Schneider, et al.AIDS (London, England)|November 1, 1992
Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled studyM A Conant, L H Calabrese, S E Thompson, et al.Archives of Neurology|December 1, 1986
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosisD L Camenga, K P Johnson, M Alter, et al.Pageof 5